Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia

NCT05032599 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
19
Enrollment
OTHER
Sponsor class

Stopped ethic commitee decision

Conditions

Interventions

Sponsor

Beijing Boren Hospital